OCA
GPCR icon

Octagon Capital Advisors’s Structure Therapeutics GPCR Stock Holding History

Octagon Capital Advisors’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-115,000
Closed -$3.22M – 31
2025
Q3 		$3.22M Buy
+115,000
New +$2.29M 0.5% 26
2024
Q4 		– Sell
-1,198,000
Closed -$52.6M – 40
2024
Q3 		$52.6M Buy
1,198,000
+57,940
+5% +$2.24M 8.42% 3
2024
Q2 		$44.8M Buy
1,140,060
+633,456
+125% +$26M 7.39% 3
2024
Q1 		$21.7M Buy
506,604
+92,604
+22% +$3.9M 2.64% 11
2023
Q4 		$16.9M Buy
+414,000
New +$23.7M 2.7% 10
2023
Q3 		– Sell
-75,000
Closed -$3.12M – 42
2023
Q2 		$3.12M Sell
75,000
-18,692
-20% -$524K 0.44% 30
2023
Q1 		$2.23M Buy
+93,692
New +$2.2M 0.32% 31

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return